- Home
- BKTI vs GALT Comparison
BKTI vs GALT Comparison
Compare BKTI & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKTI | GALT |
|---|---|---|
| Founded | 1997 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.0M | 297.0M |
| IPO Year | 2000 | 2008 |
Fundamental Metrics
Financial Performance| Metric | BKTI | GALT |
|---|---|---|
| Price | $71.60 | $4.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $74.00 | $8.50 |
| AVG Volume (30 Days) | 27.5K | ★ 326.7K |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.89 | 36.84 |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $74,094,000.00 | N/A |
| Revenue This Year | $6.57 | N/A |
| Revenue Next Year | $15.00 | N/A |
| P/E Ratio | $49.23 | ★ N/A |
| Revenue Growth | ★ 45.42 | N/A |
| 52 Week Low | $60.00 | $2.03 |
| 52 Week High | $104.55 | $7.13 |
Technical Indicators
Market Signals| Indicator | BKTI | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 36.11 | 57.77 |
| Support Level | $60.97 | $2.74 |
| Resistance Level | $79.75 | $4.35 |
| Average True Range (ATR) | 2.66 | 0.28 |
| MACD | -0.38 | 0.06 |
| Stochastic Oscillator | 4.75 | 63.95 |
Price Performance
Historical ComparisonAbout BKTI BK Technologies Corporation
BK Technologies Corp is a holding company that, through BK Technologies, Inc., its operating subsidiary, provides public safety-grade communications products and services designed to make first responders safer and more efficient. All operating activities described herein are undertaken by its operating subsidiary. The Company has one reportable segment - Land Mobile Radio (LMR) Products and Solutions. The LMR segment provides radio devices that are hand-held (portable) or installed in vehicles (mobile) and operate on private radio systems that are P25 compliant. The Company derives revenue in North America and manages the business activities on a consolidated basis.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.